- 专利标题: Isoxazole hydroxamic acid compounds as LpxC inhibitors
-
申请号: US15375560申请日: 2016-12-12
-
公开(公告)号: US09815804B2公开(公告)日: 2017-11-14
- 发明人: Jiping Fu , Xianming Jin , Subramanian Karur , Guillaume Lapointe , Ann Marie Madera , Zachary Kevin Sweeney
- 申请人: Novartis AG
- 申请人地址: CH Basel
- 专利权人: Novartis AG
- 当前专利权人: Novartis AG
- 当前专利权人地址: CH Basel
- 代理商 Mark H. Hopkins
- 主分类号: C07D261/08
- IPC分类号: C07D261/08 ; A61K31/42 ; A61K45/06 ; C07D413/12 ; A61K31/422 ; C07D413/06
摘要:
This invention pertains generally to compounds of Formula I as described herein and compositions containing such compounds, as well as methods of using such compounds to treat bacterial infections. In certain aspects, the invention provides methods and compositions comprising these compounds for treating infections caused by Gram-negative bacteria.
公开/授权文献
- US20170088525A1 ISOXAZOLE HYDROXAMIC ACID COMPOUNDS AS LpxC INHIBITORS 公开/授权日:2017-03-30
信息查询